|
 |
 |
 |
 |
 |
 |
 |
 |
| Copyright © 2005-2010 Life Herbal, Inc. - All rights reserved. |
Get Flash to see the video below...
| Protazen's formula is designed to: |
 | Support a positive outlook | |
| Improve emotional well-being | |
| Improve mental clarity | |
| Increase energy during the day | |
| Sharpen short and long-term | |
| memory | ||
| Relax the body at night in order | |
| to induce a normal sleep |
 |
 |
| *Although the FDA has deemed our ingredients safe for sale as dietary supplements, these statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This site is intended for informational purposes only and should not be interpreted as specific medical advice. If you have a specific medical condition or take particular medication, it is best that you consult with a medical professional before beginning any new supplement regimen (including Protazen). |
"DL-Phenylalanine"
Supporting Research and Studies
Supporting Research and Studies
- Beckmann H, Strauss MA, Ludolph E. “Dl-phenylalanine in
depressed patients: an open study.” J Neural Transm. 1977;
41(2-3):123-34. - Beckmann H, Athen D, Olteanu M, Zimmer R. “DL-
phenylalanine versus imipramine: a double-blind controlled
study.” Arch Psychiatr Nervenkr. 1979 Jul 4; 227(1): 49-58. - Bagchi SP, Smith TM. “Dopa and dopamine formation from
phenylalanine in human brain.” Biochem Pharmacol. 1977
May 1; 26(9): 900-2. - Borison RL, Maple PJ, Havdala HS, Diamond BI.
“Metabolism of an amino acid with antidepressant
properties.” Res Commun Chem Pathol Pharmacol. 1978
Aug; 21(2): 363-6. - Friedman M, and Gumbmann MR, “The nutritive value and
safety of D-phenylalanine and D-tyrosine in mice.” J. Nutr.
1994; 2089-2096 - Heller B. “Pharmacological and clinical effects of D-
phenylalanine in depression and Parkinson’s disease.” In:
Mosnaim AD, Wolf ME, eds. Noncatecholic
Phenylethylamines. Part 1. New York, NY: Marcel Dekker;
1978:397-417.